Mona Landin‐Olsson

10.3k citations
197 papers · 7.5k indexed · 1 hit paper · h-index 48
Topics
Diabetes and associated disorders (114 papers)Pancreatic function and diabetes (87 papers)Diabetes Management and Research (77 papers)

In The Last Decade

Mona Landin‐Olsson

193 papers receiving 7.2k citations

Hit Papers

Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Su...20042026201120182004200400600

Peers

Mona Landin‐Olsson
Comparison fields: 5 of 140
  • Endocrinology, Diabetes and Metabolism 4.6k
  • Genetics 3.9k
  • Surgery 3.7k
  • Molecular Biology 784
  • Immunology 720
Replace Edwin Gale with:
Edwin Gale United Kingdom
Peter Almgren Sweden
Yasuhiko Iwamoto Japan
Christophe De Block Belgium
Peter G. Colman Australia
Stephen C. Bain United Kingdom
Stefan S. Fajans United States
Jorge Luiz Gross Brazil
Carmella Evans‐Molina United States
Christopher Newton‐Cheh United States
Mona Landin‐Olsson relative to Edwin Gale United Kingdom Edwin Gale's profile →
Citations per field
00.5×1.5×1.9×
Edwin Gale · 1×
Citations per year

Countries citing papers authored by Mona Landin‐Olsson

Since Specialization
Citations

This map shows the geographic impact of Mona Landin‐Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Landin‐Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Landin‐Olsson more than expected).

Fields of papers citing papers by Mona Landin‐Olsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Landin‐Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Landin‐Olsson. The network helps show where Mona Landin‐Olsson may publish in the future.

Co-authorship network of co-authors of Mona Landin‐Olsson

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Landin‐Olsson. A scholar is included among the top collaborators of Mona Landin‐Olsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Landin‐Olsson. Mona Landin‐Olsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 9
3 13
4 23
5 78
6 25
7 11
8
[HbA1c--new standardization introduced in Sweden. The new unit is mmol/mol].
7
9
TbA1c--ny standardisering införs i Sverige. Den nya enheten blir mmol/mol.
1
10 59
11 58
12 152
13 10
14 32
15 93
16 11
17 9
18 351
19 160
20 91

About Mona Landin‐Olsson

Mona Landin‐Olsson is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery, having authored 197 papers that have together received 7.5k indexed citations. Recurring topics across this work include Diabetes and associated disorders (114 papers), Pancreatic function and diabetes (87 papers) and Diabetes Management and Research (77 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.6k citations), Genetics (3.9k citations) and Surgery (3.7k citations). Mona Landin‐Olsson has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Åke Lernmark, G. Sundkvist, Gisela Dahlquist, Ingrid Kockum, Per‐Anders Jansson, David Holmes, Bo Åhrén, Carina Törn, Maria Svensson and Håkan Olsson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026